Evidence-Based Management of Alzheimer’s Disease: Best Practices and Future Directions

Program Overview

Many patients with Alzheimer’s disease (AD) experience delayed diagnoses, which deprives them and their caregivers of interventions that can extend cognitive integrity and quality of life, delay placement in long-term care, minimize burden on caregivers, and reduce overall costs. The lack of disease-modifying agents for AD contributes to clinical inertia and leads clinicians to overlook adjunctive therapies for comorbidities and behavioral and psychological problems.

“Evidence-based Management of Alzheimer’s Disease: Best Practices and Future Directions,” will reinforce the need for early recognition of mild cognitive impairment and early cognitive decline. The activity will review the profiles of current and emerging AD treatment options and discuss the implementation of multidisciplinary collaborative care to provide the best possible outcomes for patients with AD.
Learning Objectives

Upon completion of this activity, participants should be able to:

Describe the critical importance of early recognition of mild cognitive impairment and early cognitive decline
Outline the mechanisms of action, efficacy and safety profiles, and places in treatment regimens of current and emerging treatment options for Alzheimer’s disease
Describe neurologist-led initiatives to establish multidisciplinary collaborative-care models for Alzheimer’s disease and action-based steps for implementation of similar programs